Functional Ability and Health-Related Quality of Life in Randomized Controlled Trials of Tocilizumab in Patients With Juvenile Idiopathic Arthritis.

Hermine I BrunnerChen ChenFrancesca Bovis Fabrizio De BenedettiGraciela EspadaRik JoosJonathan AkikusaJeffrey ChaitowAlina Lucica BoteanuYukiko KimuraChristoph RietschelDaniel SiriElzbieta SmolewskaHeinrike SchmelingDiane E BrownAlberto MartiniDaniel J LovellBin HuangNicolino Rupertonull null

Published in: Arthritis care & research (2021)

Tocilizumab treatment was associated with significantly reduced disability and pain and improved HRQoL in patients with systemic JIA and polyarticular JIA.

Keyphrases

juvenile idiopathic arthritis
disease activity
randomized controlled trial
chronic pain
multiple sclerosis
rheumatoid arthritis
neuropathic pain
pain management
systematic review
spinal cord injury
combination therapy
rheumatoid arthritis patients
replacement therapy
drug induced